Related references
Note: Only part of the references are listed.Characterization of circulating APOL1 protein complexes in African Americans
Allison Weckerle et al.
JOURNAL OF LIPID RESEARCH (2016)
Population genomics reveals the origin and asexual evolution of human infective trypanosomes
William Weir et al.
ELIFE (2016)
Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: Relevance to trypanosome lysis
Russell Thomson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The in vivo dynamics of antigenic variation in Trypanosoma brucei
Monica R. Mugnier et al.
SCIENCE (2015)
Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1
Gilles Vanwalleghem et al.
NATURE COMMUNICATIONS (2015)
Plasma Apolipoprotein L1 Levels Do Not Correlate with CKD
Leslie A. Bruggeman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The molecular arms race between African trypanosomes and humans
Etienne Pays et al.
NATURE REVIEWS MICROBIOLOGY (2014)
Evolution of the primate trypanolytic factor APOL1
Russell Thomson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Cathepsin-L Can Resist Lysis by Human Serum in Trypanosoma brucei brucei
Sam Alsford et al.
PLOS PATHOGENS (2014)
End-Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1
Barry I. Freedman et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis
Pere P. Simarro et al.
INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS (2014)
Baboon Phylogeny as Inferred From Complete Mitochondrial Genomes
Dietmar Zinner et al.
AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY (2013)
Apolipoprotein L1 Risk Variants Associate with Systemic Lupus Erythematosus-Associated Collapsing Glomerulopathy
Christopher P. Larsen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Do we need new drugs against human African trypanosomiasis?
August Stich et al.
LANCET INFECTIOUS DISEASES (2013)
Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
Peter G. E. Kennedy
LANCET NEUROLOGY (2013)
Mechanism of Trypanosoma brucei gambiense resistance to human serum
Pierrick Uzureau et al.
NATURE (2013)
Structure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunity
Matthew K. Higgins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Single Amino Acid Substitution in the Group 1 Trypanosoma brucei gambiense Haptoglobin-Hemoglobin Receptor Abolishes TLF-1 Binding
E. DeJesus et al.
PLOS PATHOGENS (2013)
The TgsGP Gene Is Essential for Resistance to Human Serum in Trypanosoma brucei gambiense
Paul Capewell et al.
PLOS PATHOGENS (2013)
Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis
P. P. Simarro et al.
PARASITOLOGY (2012)
Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors
Whitney Bullard et al.
VIRULENCE (2012)
Estimating and Mapping the Population at Risk of Sleeping Sickness
Pere P. Simarro et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Endosomal Localization of the Serum Resistance-Associated Protein in African Trypanosomes Confers Human Infectivity
Natalie A. Stephens et al.
EUKARYOTIC CELL (2011)
Drug resistance in human African trypanosomiasis
Michael P. Barrett et al.
FUTURE MICROBIOLOGY (2011)
Development of novel drugs for human African trypanosomiasis
Reto Brun et al.
FUTURE MICROBIOLOGY (2011)
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
Jeffrey B. Kopp et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Phylogeography and Taxonomy of Trypanosoma brucei
Oliver Balmer et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Differences between Trypanosoma brucei gambiense Groups 1 and 2 in Their Resistance to Killing by Trypanolytic Factor 1
Paul Capewell et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Discovery of Novel Orally Bioavailable Oxaborole 6-Carboxamides That Demonstrate Cure in a Murine Model of Late-Stage Central Nervous System African Trypanosomiasis
Bakela Nare et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Conserved sequence of the TgsGP gene in Group 1 Trypanosoma brucei gambiense
Wendy Gibson et al.
INFECTION GENETICS AND EVOLUTION (2010)
The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill
Benoit Vanhollebeke et al.
MOLECULAR MICROBIOLOGY (2010)
Prophylactic Antiparasitic Transgenesis for Human Parasitic Disease?
Julius Lukes et al.
MOLECULAR THERAPY (2010)
Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor
Rudo Kieft et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
Giulio Genovese et al.
SCIENCE (2010)
The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases
Pere P. Simarro et al.
INTERNATIONAL JOURNAL OF HEALTH GEOGRAPHICS (2010)
Membrane Permeabilization by Trypanosome Lytic Factor, a Cytolytic Human High Density Lipoprotein
John M. Harrington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto et al.
LANCET (2009)
Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes
Russell Thomson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
C-Terminal Mutants of Apolipoprotein L-I Efficiently Kill Both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense
Laurence Lecordier et al.
PLOS PATHOGENS (2009)
Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model
Maria Pilar Molina-Portela et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics
Philippe Holzmuller et al.
MICROBES AND INFECTION (2008)
A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans
Benoit Vanhollebeke et al.
SCIENCE (2008)
Molecular tools for the rapid detection of drug resistance in animal trypanosomes
Vincent Delespaux et al.
TRENDS IN PARASITOLOGY (2008)
Hemoglobin is a co-factor of human trypanosome lytic factor
Justin Widener et al.
PLOS PATHOGENS (2007)
Distinct roles of haptoglobin-related protein and apolipoprotein L-1 in trypanolysis by human serum
Benoit Vanhollebeke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The function of apolipoproteins L
B. Vanhollebeke et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
Toya Nath Baral et al.
NATURE MEDICINE (2006)
The trypanolytic factor of human serum
Etienne Pays et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes
MD Molina-Portela et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2005)
Allelic segregation and independent assortment in T-brucei crosses:: Proof that the genetic system is Mendelian and involves meiosis
A MacLeod et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2005)
Apolipoprotein L-1 promotes trypanosome lysis by forming pores in lysosomal membranes
D Pérez-Morga et al.
SCIENCE (2005)
Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera
P Poelvoorde et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2004)
Characterization of primate trypanosome lytic factors
EB Lugli et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2004)
Human infectivity trait in Trypanosoma brucei:: stability, heritability and relationship to sra expression
CMR Turner et al.
PARASITOLOGY (2004)
Conservation of the genomic location of the human serum resistance associated gene in Trypanosoma brucei rhodesiense
W Gibson et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)
Apolipoprotein L-I is the trypanosome lytic factor of human serum
L Vanhamme et al.
NATURE (2003)
Evidence for a Trypanosoma brucei lipoprotein scavenger receptor
HP Green et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense
M Radwanska et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense
M Radwanska et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes
J Drain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Trypanosome lytic factors: novel mediators of human innate immunity
J Raper et al.
CURRENT OPINION IN MICROBIOLOGY (2001)
A receptor-like flagellar pocket glycoprotein specific to Trypanosoma brucei gambiense
M Berberof et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2001)
Share Paper
